Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Galina Smushkin, Adrian Vella

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences